Study Stopped
No participant were enrolled
Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment, Young Adults and Adults
Clinical Trial Protocol for the Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment, Young Adults and Adults
1 other identifier
observational
N/A
1 country
1
Brief Summary
Concussion is widely recognized as a major public health concern in the United States and worldwide. Although many concussions resolve completely and spontaneously, almost 1 in 4 patients will go on to experience post-concussion syndrome (PCS). In the United States, PCS diagnoses have increased 100% from 2010-2015. Concurrently, recent advances in EEG evoked response potential analysis have led to a novel technique for assessing brain network activation (BNA) patterns. The purpose of this study is to explore the use of BNA in individuals who are diagnosed with PCS or have the risk of experiencing PCS due to a recent injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2017
CompletedFirst Submitted
Initial submission to the registry
August 8, 2017
CompletedFirst Posted
Study publicly available on registry
August 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2019
CompletedSeptember 28, 2018
September 1, 2018
1.5 years
August 8, 2017
September 26, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Developing a BNA database for concuss population.
Functional networks of brain activity in healthy individuals measured using analysis of EEG Event Related Potential (ERP) data
This study duration is 18 months
Study Arms (2)
ARM 1
ARM 1: Retrospective Arm: Subjects tested with BNA in the past and have been diagnosed by their physician as having Post Concussive Syndrome. Study staff will contact the subjects and obtain Informed Consent. Study physicians will then review both BNA data and Clinical data. All relevant clinical data and all available BNA data will be shared with ElMindA. Subjects may be invited for an additional BNA follow up as part of the study.
ARM 2
ARM 2: Subjects will be prospectively enrolled in the study at the following time points when available: * Acute: within 2 weeks of injury * PCS: Subjects which sustained a concussion in the past 3 months or more, and are still experiencing symptoms related to the injury
Eligibility Criteria
Adolescents, young adults and adults of both genders.
You may qualify if:
- Males and females Aged 12-50
- Willingness to participate in the study and the ability to give informed assent (for children) and/or consent (for the parent of a minor or adults aged 18 years of age or older for themselves).
- Subjects that are or were diagnosed with mTBI according to the standard diagnostic procedures at the investigational site in a timeframe that meets enrollment criteria.
- Subjects that are experiencing symptoms of concussion or Post-concussion Syndrome at the time of their initial test session.
You may not qualify if:
- Subjects that have undergone neuroimaging with identification of intracranial structural pathology.
- Self-reported history of central nervous system injury other than mTBI, or disease (examples will include, but will not be limited to, moderate or severe traumatic brain injury (TBI with a Glasgow Coma Scale \< 13) epilepsy, seizures, brain surgery)
- Neuropsychological disorder such as autistic spectrum disorder
- Any history of a learning disability (examples include, but will not be limited to, dyslexia, dysgraphia, dyscalculia, or a nonverbal learning disorder)
- Use of any medication affecting central nervous system (CNS) in the past 3 months prior to their BNA (i.e. antidepressants, anticonvulsants, psychostimulants, first generation antihistamines, etc.)
- Active head lice infection
- Open scalp wound
- baldness, dread locks or hair that is otherwise sufficiently long and thick so as to preclude appropriate scalp electrode cap fit
- Deafness, and/or blindness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ElMindA Ltdlead
Study Sites (1)
The Sports Neurology Clinic at The CORE Institute
Brighton, Michigan, 48114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey Kutcher, MD
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2017
First Posted
August 15, 2017
Study Start
July 5, 2017
Primary Completion
January 1, 2019
Study Completion
January 1, 2019
Last Updated
September 28, 2018
Record last verified: 2018-09